AIZ
63
6
STX
60
3
UHS
62
2
SE
55
12
CSX
48
-2
NSC
45
-3
VNO
52
3
ROST
70
-3
BEN
46
-2
SLG
74
3
O
35
-2
UPS
46
-4
SLB
56
4
AES
55
3
CF
42
-3
SBUX
33
-3
IVZ
50
-3
JNJ
23
-3
DVN
28
3
RIG
35
4
AIZ
63
6
STX
60
3
UHS
62
2
SE
55
12
CSX
48
-2
NSC
45
-3
VNO
52
3
ROST
70
-3
BEN
46
-2
SLG
74
3
O
35
-2
UPS
46
-4
SLB
56
4
AES
55
3
CF
42
-3
SBUX
33
-3
IVZ
50
-3
JNJ
23
-3
DVN
28
3
RIG
35
4
Financhill
Back

Phathom Pharmaceuticals Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Buy
62

PHAT
Phathom Pharmaceuticals

Last Price:
10.31
Seasonality Move:
-8.21%
Sell
47

RARE
Ultragenyx Pharmaceutical

Last Price:
41.06
Seasonality Move:
-0.9%
Buy
62
Phathom Pharmaceuticals (PHAT) is a Buy

Is Phathom Pharmaceuticals a Buy, Sell or Hold?

  • The current Phathom Pharmaceuticals [PHAT] share price is $10.40. The Score for PHAT is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
  • PHAT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
47
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $41.42. The Score for RARE is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PHAT Stock Price Chart

What is Phathom Pharmaceuticals's stock price today?

  • The Phathom Pharmaceuticals share price today is $10.40
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PHAT is experiencing buying pressure, which is a positive indicator for future bullish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $41.42
    The current trend is relatively stagnant and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

PHAT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.12 Buy
Relative Strength Index (14 RSI): 46.94 Sell
Chaikin Money Flow: 338683 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (10.03 - 11.23) Sell
Bollinger Bands (100): (8.52 - 11.08) Buy

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.45 Sell
Relative Strength Index (14 RSI): 52.47 Buy
Chaikin Money Flow: 873891 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.82 - 42.02) Buy
Bollinger Bands (100): (40.78 - 48.78) Sell

PHAT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 11.03 Sell
20-day SMA: 10.71 Sell
50-day SMA: 10.22 Buy
200-day SMA: 9.3 Buy
8-day EMA: 10.73 Sell
20-day EMA: 10.73 Sell
50-day EMA: 10.39 Buy
200-day EMA: 9.97 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 39.5 Buy
20-day SMA: 40.58 Buy
50-day SMA: 41.51 Sell
200-day SMA: 42.46 Sell
8-day EMA: 40.23 Buy
20-day EMA: 40.49 Buy
50-day EMA: 41.77 Sell
200-day EMA: 43.33 Sell

Phathom Pharmaceuticals Earnings Growth & PHAT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.26 per share, an increase next quarter of $0.34 per share, a decrease this year of $1.15 per share, and an increase next year of $1.18 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.51 per share, an increase next quarter of $0.03 per share, an increase this year of $0.94 per share, and an increase next year of $1.06 per share.

Phathom Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):